Tag: biosimilars
Authorized Biologic Alternatives: Understanding Biosimilars vs Generics
Apr, 11 2026Explore the difference between biosimilars and authorized generics. Learn about interchangeable biologics, FDA approval paths, and how they lower healthcare costs.
READ MORE
Immunogenicity in Biosimilars: Understanding Immune Response Variations
Mar, 29 2026Explore why immunogenicity responses may vary between biosimilars and reference biologics, covering mechanisms, risk factors, and real-world evidence.
READ MORE
The Purple Book: Understanding Biosimilars and Interchangeability from the FDA
Dec, 20 2025The FDA's Purple Book is the official guide to biosimilars and interchangeable biological products in the U.S. Learn how it works, what the difference is between biosimilar and interchangeable, and how state laws affect substitution.
READ MORE